3M (NYSE: MMM) has completed the sale of its Asia-Pacific pharmaceutical operations to Ironbridge Capital and Archer Capital (both of < ?XML:NAMESPACE PREFIX = ST1 />Australia) for $349 million. www.3m.com
3M (NYSE: MMM) has completed the sale of its Asia-Pacific pharmaceutical operations to Ironbridge Capital and Archer Capital (both of < ?XML:NAMESPACE PREFIX = ST1 />Australia) for $349 million. www.3m.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: